Ultralife (NASDAQ:ULBI – Get Free Report) announced its quarterly earnings results on Tuesday. The technology company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.14), RTT News reports. Ultralife had a net margin of 5.44% and a return on equity of 7.92%. The firm had revenue of $43.85 million for the quarter, compared to analyst estimates of $40.00 million. During the same quarter in the prior year, the firm earned $0.18 earnings per share.
Ultralife Stock Down 3.4 %
Shares of ULBI stock opened at $4.88 on Thursday. The company has a market capitalization of $81.14 million, a price-to-earnings ratio of 8.87 and a beta of 1.05. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.62 and a current ratio of 3.30. The stock’s 50 day simple moving average is $6.50 and its 200 day simple moving average is $7.63. Ultralife has a twelve month low of $4.42 and a twelve month high of $13.39.
Wall Street Analyst Weigh In
Separately, StockNews.com cut shares of Ultralife from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th.
Hedge Funds Weigh In On Ultralife
A hedge fund recently raised its stake in Ultralife stock. Bank of America Corp DE boosted its position in Ultralife Co. (NASDAQ:ULBI – Free Report) by 30.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,067 shares of the technology company’s stock after buying an additional 2,836 shares during the quarter. Bank of America Corp DE owned approximately 0.07% of Ultralife worth $90,000 at the end of the most recent reporting period. 30.68% of the stock is currently owned by hedge funds and other institutional investors.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading
- Five stocks we like better than Ultralife
- How to Calculate Inflation Rate
- 5 Reasons the S&P 500 Could Rebound Strongly in 2025
- Election Stocks: How Elections Affect the Stock Market
- Best Gold Stocks in 2025… So Far
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 5 Reasons Why Halliburton is a Good Buy in 2025
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.